Present results from the Phase 1b portion of the DEDUCTIVE study
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 12 Jan 2021
- Due
- 15 Jan 2021
- Delivered
- 15 Jan 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Results from the Phase 1b portion of the DEDUCTIVE study are expected to be presented at on Friday, January 15, 2021”
What we found
Evidence strength A What the grades mean
The company presented preliminary results from the Phase 1b portion of the DEDUCTIVE trial at the ASCO GI Cancers Symposium in January 2021, meeting the January 15, 2021 deadline.
-
A Aveo Pharmaceuticals, Inc. 10-Q filed 2021-05-10
“In January 2021, we presented preliminary results from the phase 1b portion of the DEDUCTIVE trial in a poster session at the 2021 American Society of Clinical Oncology Gastrointestinal, or ASCO GI, Cancers Symposium.” ✓ confirmed on the page
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Present
- Deliverable
- Phase 1b DEDUCTIVE study results
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Aveo Pharmaceuticals, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C325879-021925 · Corrections policy